Skip to main content

and
  1. Article

    Open Access

    Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)

    Pancreatic cancer is susceptible to gemcitabine resistance, and patients receive less benefit from gemcitabine chemotherapy. Previous studies report that gambogic acid possesses antineoplastic properties; howe...

    Guanggai **a, Hongcheng Wang, Ziliang Song in Journal of Experimental & Clinical Cancer … (2017)